We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience. By continuing to use our site, you agree to the use of cookies. Learn more about cookies.
Orion: Annual Summary of Stock Exchange Releases and Announcements published in 2007
7 February 2008 at 9.35 a.m.
|
24.01.2007 |
Change in the Executive Management Board of the Orion Group as of 1 February 2007 |
|
24.01.2007 |
Share-based incentive plan for ca. 30 key persons in Orion |
|
29.01.2007 |
Recommendation by the Nomination Committee concerning Board of Directors to be elected by the AGM of Orion Corporation |
|
06.02.2007 |
Bulletin of Orion Corporation Financial Statements for 1 July - 31 December 2006 |
|
06.02.2007 |
Orion Group Financial Review (proforma) 1-12/2006 |
|
06.02.2007 |
Orion updates progress with Simdax (i.v. levosimendan): |
|
06.02.2007 |
Matters to be handled at Orion's AGM on 2 April 2007 |
|
01.03.2007 |
Orion Group Annual Report 2006 published |
|
08.03.2007 |
Amendment to the Annual Report 2006 of Orion Corporation concerning holdings of Board members |
|
02.04.2007 |
Decisions by the AGM of Orion Corporation on 2 April 2007 |
|
02.04.2007 |
Jukka Ylppö Vice Chairman of the Board of Directors of Orion Corporation. Compositions of Board committees |
|
25.04.2007 |
Orion's partner discontinues development of levosimendan (Simdax) in the US |
|
25.04.2007 |
Orion Group Interim Report 1-3/2007 |
|
06.08.2007 |
Orion Group Interim Report 1-6/2007 |
|
06.08.2007 |
Decision of the Board of Directors of Orion on repurchasing own shares |
|
13.08.2007 |
Orion comments on ANDA filing of generic entacapone (Orion's proprietary drug Comtan®) in the United States |
|
11.09.2007 |
New President and CEO for Orion Corporation as of 1 January 2008 |
|
13.09.2007 |
Orion sues generic drug companies in the U.S. to enforce patents for entacapone (Orion's proprietary drug Comtan®) |
|
01.10.2007 |
Orion comments on ANDA filing of generic versions of Orion's proprietary drug Stalevo® in the United States |
|
24.10.2007 |
Orion Group Interim Report 1-9/2007 |
|
24.10.2007 |
Orion Corporation's publication schedules for financial reporting in 2008 |
|
24.10.2007 |
Composition of the Nomination Committee of Orion Corporation |
|
13.11.2007 |
Orion sues Sun Pharmaceuticals in the U.S. to enforce a patent for Stalevo® |
|
15.11.2007 |
Appointments into Orion's Executive Management Board as of 1 January 2008 |
|
27.11.2007 |
Announcement by Orion Corporation in accordance with section 10 of chapter 2 of the Finnish Securities Market Act |
|
18.01.2007 |
223,000 Orion A-shares converted into B-shares |
|
26.01.2007 |
70,000 Orion A-shares converted into B-shares |
|
19.04.2007 |
Changes in Orion's Articles of Association entered in the Trade Register on 19 April 2007 |
|
26.04.2007 |
905,839 Orion A-shares converted into B-shares |
|
21.05.2007 |
532,051 Orion A-shares converted into B-shares |
|
21.06.2007 |
335,315 Orion A-shares converted into B-shares |
|
06.07.2007 |
100,000 Orion A-shares converted into B-shares |
|
31.08.2007 |
398,000 Orion A-shares converted into B-shares |
|
07.11.2007 |
171,347 Orion A-shares converted into B-shares |
|
17.12.2007 |
260,000 Orion A-shares converted into B-shares |
